BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30880253)

  • 1. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
    Nakajima Y; Ito S; Asakura M; Min KD; Fu HY; Imazu M; Hitsumoto T; Takahama H; Shindo K; Fukuda H; Yamazaki S; Asanuma H; Kitakaze M
    J Mol Cell Cardiol; 2019 Apr; 129():257-265. PubMed ID: 30880253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
    Esposito G; Cappetta D; Russo R; Rivellino A; Ciuffreda LP; Roviezzo F; Piegari E; Berrino L; Rossi F; De Angelis A; Urbanek K
    Br J Pharmacol; 2017 Nov; 174(22):4070-4086. PubMed ID: 27922176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
    Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N
    Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
    Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
    Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.
    Yamamoto M; Ishizu T; Seo Y; Suto Y; Sai S; Xu D; Murakoshi N; Kimura T; Kawakami Y; Aonuma K
    J Card Fail; 2018 Jan; 24(1):53-60. PubMed ID: 28888840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice.
    Takahashi A; Asakura M; Ito S; Min KD; Shindo K; Yan Y; Liao Y; Yamazaki S; Sanada S; Asano Y; Ishibashi-Ueda H; Takashima S; Minamino T; Asanuma H; Mochizuki N; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1361-9. PubMed ID: 23504176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
    Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
    Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Peroxisome Proliferator-activated Receptor γ Prevents Development of Heart Failure With Preserved Ejection Fraction; Inhibition of Wnt-β-catenin Signaling as a Possible Mechanism.
    Kamimura D; Uchino K; Ishigami T; Hall ME; Umemura S
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):155-61. PubMed ID: 27046338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats.
    Sufiun A; Rafiq K; Fujisawa Y; Rahman A; Mori H; Nakano D; Kobori H; Ohmori K; Masaki T; Kohno M; Nishiyama A
    Hypertens Res; 2015 Apr; 38(4):237-43. PubMed ID: 25588850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure.
    Kim S; Yoshiyama M; Izumi Y; Kawano H; Kimoto M; Zhan Y; Iwao H
    Circulation; 2001 Jan; 103(1):148-54. PubMed ID: 11136700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
    Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
    Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin-angiotensin system in hypertensive rats.
    Fukui S; Fukumoto Y; Suzuki J; Saji K; Nawata J; Shinozaki T; Kagaya Y; Watanabe J; Shimokawa H
    Hypertens Res; 2009 Jun; 32(6):472-80. PubMed ID: 19390543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction.
    Klotz S; Hay I; Zhang G; Maurer M; Wang J; Burkhoff D
    Hypertension; 2006 May; 47(5):901-11. PubMed ID: 16585423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
    Akahori H; Tsujino T; Naito Y; Matsumoto M; Sasaki N; Iwasaku T; Eguchi A; Sawada H; Hirotani S; Masuyama T
    J Hypertens; 2014 Jul; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction.
    Cho JH; Zhang R; Kilfoil PJ; Gallet R; de Couto G; Bresee C; Goldhaber JI; Marbán E; Cingolani E
    Circulation; 2017 Nov; 136(21):2037-2050. PubMed ID: 28974519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.
    Aroor AR; Habibi J; Kandikattu HK; Garro-Kacher M; Barron B; Chen D; Hayden MR; Whaley-Connell A; Bender SB; Klein T; Padilla J; Sowers JR; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2017 May; 16(1):61. PubMed ID: 28476142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive assessment of diastolic function in subjects with preserved left ventricular ejection fraction: usefulness of color kinetic imaging.
    Takeda Y; Sakata Y; Mano T; Nishio M; Ohtani T; Hori M; Masuyama T; Yamamoto K
    J Card Fail; 2008 Sep; 14(7):569-76. PubMed ID: 18722322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.